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Abstract  
Introduction: Sickle Cell Disease (SCD) has a high mortality rate in the environment where we practice. There is lack of contemporal autopsy 
studies describing causes of death among SCD patients at our centre. Methods: This is a retrospective study of SCD patients who died between 
January 1991 and December 2008 and that had autopsy examination to confirm the cause of death in a Nigerian teaching hospital. The clinical 
data, including the age, gender, Hb genotype, and the major autopsy findings and cause of death were obtained for each patient from the 
complete autopsy reports that included histopathological examination. Multiple causes of death were entertained. Results: A total of 52 autopsies 
were performed. The mean age at death was 21.3 years (range, 1-47 years) and a male/female ratio of 1.3:1. HbS+C patients lived longer than 
HbS patients (21.0 years Vs 24.0 years) and peak mortality was in the 2nd and 3rd decades of life. The commonest causes of death as a single 
entity or in combination included infections in 78% of cases, fatal thrombotic/embolic events (37%) making acute chest syndrome a leading cause 
of death. This was followed closely by anemia alone or in combination with acute sequestration crises in 31% of patients. Conclusion: Infections 
are the commonest causes of death in Nigerian SCD patients, efforts to reduce infection especially early in life through prophylaxis or vaccination 
will impact on the overall survival of these patients. 
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Sickle cell disease (SCD) describes the conditions in which the 
haemoglobin (Hb)S gene is inherited with another abnormal β chain 
gene, which include the homozygote state (HbSS) and the double 
heterozygote state (HbSC or HbS- β thalassaemia). The homozygote 
state also known as sickle cell anemia (SCA) is the commonest 
variant and has the severest clinical manifestations of any of the 
SCD variants. The heterozygote state (sickle cell trait or HbAS) is 
usually normal phenotypically. Sickle cell disease is the commonest 
haemoglobinopathy and single gene disorder in black Africans. In 
the Nigerian population, carrier rate for the trait (HbAS) is about 
25% while 2-3% suffers from SCA [1]. Diagnosis of SCD in Nigeria 
is by haemoglobin electrophoresis at alkaline pH alone, so patients 
are either diagnosed as HbS or HbS+C and a report is stuck on the 
case file of the patients. Such reports may however be missing in 
some patients if the case file becomes voluminous and a new file is 
opened. Autopsies are performed at the request of the 
Haematologist after the demise of a patient in the hospital after 
obtaining consent from the relatives and rarely when a patient is 
brought in dead after having died at home or while in transit to the 
hospital. We sought to investigate the pattern and causes of 
mortality in SCD at our centre, with emphasis on the causes of 
death among SCD patients at our hospital. We believe that the 
findings of the study would help direct clinical management to focus 
attention on these specific causes of death, which with good 
management and policy may improve morbidity and mortality. This 
will be by the way of aiding clinical preparedness, streamlining 
patient counseling and enabling preventive therapies. In addition, it 
will add to the existing epidemiological data, knowledge of the 





This is a retrospective study of SCD patients who died between 
January 1991 and December 2008 and had autopsy examination to 
confirm the cause of death at the Department of Pathology, 
University College Hospital, Ibadan. The clinical history/data, 
including the age, gender, Hb genotype, and the major autopsy 
findings and cause of death were obtained for each patient from the 
complete autopsy reports that included histopathological 
examination. Patients were included in the review if they were 
referred from the Haematology department as having SCD and this 
was corroborated by the report of the electrophoresis in the case 
file. The immediate and specific (diseases or conditions directly 
leading to death) cause of death were recorded according to the 
internationally accepted/ World Health Organization (WHO) medical 
certification of cause of death. Multiple or joint causes of death was 
entertained. A broad classification of the cause of death under the 
following rubrics was done- infections, thromboembolism, Severe 
Anaemia with Cardiac failure, Acute Hepatospleenic sequestration, 
Aspiration pneumonitis, Intracranial haemorrhage and Massive 
Erosive gastritis and duodenitis. This study was conducted in 
compliance with the guidelines of the Helsinki declaration on 
biomedical research in human subjects. Confidentiality of the 






A total of 52 cases were seen in the seventeen year period out of 
which 48 had electrophoresis report in the clinical notes but the 
report was missing in four. Forty (83.3%) had SCA while 8(16.6%) 
were Hb S+C. The mean age was 21.0 years with a range of 1-47 
years. HbS+C and male patients were slightly older 24 Vs 21 years 
and 22.7 Vs 19.4 years respectively. Peak mortality occured in the 
2nd and 3rd decades of life but with equal sex distribution, more 
deaths occurred however in the female child in the first decade of 
life (Figure 1). Infections and thromboembolic phenomenon were 
the major cause of death, contributing to demise in 78% and 37% 
of cases respectively (Table 1). This was followed by severe 
anemia contributed as cause of death in about 31% of cases, but 
deaths arising from anaemia was caused by sequestration into 
either or both the liver or spleen in a third of such patients (Table 
1). Infections of the respiratory system affected more than half of 
the patients (53.8%, Table 2), thromboembolic phenomenon also 
affected the respiratory system in half of the patients (Table 3) 





The finding of 52 deaths in a 17 year period does not translate to a 
low death rate in the Nigerian SCD patients, since the recorded low 
death rate may be due to the fact that family members often do not 
consent to autopsy because of religious and social reasons [2]. 
Secondly, not all deaths are reported, especially when it occurs in 
the home setting and for a disease condition that is emotionally and 
financially tasking for the family. This is especially so in early 
childhood when children will succumb to the illness as a result of 
infection or anaemia before getting to the hospital.  
  
The mean age at death of 21 years is similar to the mean age of 22 
years obtained from a clinical review of sickle cell disease patients 
about the same time in our centre [3]. This would suggest that the 
median survival of the Nigerian SCD patient is much lower than that 
of Jamaican or USA patients [4]. The mean age at death for HbSS 
and HbSC, of our patients is comparable to the findings of Manci et 
al. [5] who found a mean age at death of 20.7 years among HbSS 
patients and 25 years among HbSC patients from across several 
centres in the United States. However, this mean age at demise are 
much lower than what has been reported in other series in the 
United States [6,7], Jamaica [8], France and England [9] where the 
age at death were between 32 years and 45 years for SCA and up 
to 68 years for HbS+C. The higher survival in those studies could be 
attributed to easy access of SCD patients to health care and health 
education in the locales where these studies were done. Infection 
and thromboembolic events are leading cause of death in SCD 
patients as shown by other studies [6-10]. These were categorized 
as acute chest syndrome as done by Thomas et al and Platt et al. 
[6,8]. The study from England and France however reported vaso-
occlusion related causes as the most common cause of death but 
this was followed closely by infection [9]. Meningitis featured 
prominently as an infectious cause of death in this study, being 
responsible for 13.2% (7 out of 53) cases of deaths among our 
patients. Meningitis was similarly a major cause of death in other 
series by Thomas et al and Perronne et al where it was the 
commonest infective cause of death [8,9].  
  
SCD patients are more prone to infections because of 
autosplenectomy that occurs as a result of repeated infarction of the 
organ thus leading to the loss and inability to fight infection. 
Additionally, SCD patients have defective alternative pathway of 
complement activation and reduced ability of neutrophils to kill 
pathogenic organisms which makes them especially prone to 
infection by encapsulated organisms. Common bacterial organisms 
that have been documented to cause infection in SCD patients in 
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our environment include Salmonella typhi, E. coli, Staphylococcus 
Aureus, Haemophillus influenza and Klebsiella species [11,12], while 
Infection caused by Streptococcus pneumonia which have been 
reported by others have not been reported among SCD patients in 
our locale [11-13]. The high prevalence of infections by 
Haemophilus Influenza and Pneumococcus species in patients with 
SCD, is the reason why patients in the UK and USA are placed on 
prophylaxis and vaccinated against these organisms. The 
introduction of bacterial prophylaxis for SCD patients in Nigeria may 
therefore reduce the mortality rate especially in early childhood due 
to infections.  
  
Another important cause of death in our cohort is severe anaemia 
associated with cardiac failure, playing a significant role as cause of 
death in 21% of cases. Cardiac failure was also an important 
mechanism of death in other studies [5-7,9]. Other causes of 
cardiac failure in SCD patients may include myocardial infarction, 
arrhythmias, and cardiomyopathy [7] but these did not feature in 
our patients possibly because they do not live long enough to 
experience such complications. Organ sequestration, a spontaneous 
pooling of blood in solid and spongy viscera occur most commonly 
in the spleen, but also in the liver and lungs in SCD patients. Its 
pathogenesis is unknown but it usually follows or occurs 
concomitantly with acute viral infections, pain crisis, bacteraemia 
and stroke. It causes cardiovascular collapse and it is not an 
uncommon cause of death in this group of patients. In this study 
hepatosplenic sequestration was a cause of death in 9.6% of our 
patients, being the 4th commonest cause of death. Thomas et al 
and Pafrey et al found organ sequestration to be the second 





This study has illustrated that the commonest cause of death in the 
SCD patients in the Nigerian SCD patient is acute chest syndrome 
which may present either as infections or thromboembolism in the 
respiratory system. The use of bacterial prophylaxis early in 
childhood is expected to reduce early mortality and thus improve 
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Table 1:  Broad classification of the causes of death 
Cause  of Death Number of Cases* % 
Infections 41 78 
Thromboembolism 18 37 
Severe Anaemia  11 21 
Hepatospleenic Sequestration (with consequent 
Severe anaemia)  
5 9.6 
Aspiration pneumonitis 4 7.6 
Intracranial Haemorrhage 2 3.8 
Erosive gastritis and duodenitis 2 3.8 
*The number of cases and percentages are more than 100% because there were more than 




Table 2:  Systemic localization of infections causing death 
Infections Number of Cases Percentage 
Respiratory 22 53.8 
Cerebral 7 17.1 
Urinary Tract 7 17.1 
Disseminated Tuberculosis 2 4.8 
Endocarditis 1 2.4 
Peritonitis 1 2.4 
Cholecystitis 1 2.4 



















Figure 1: Age group and gender distribution of patients  
 
 
Table 3: Organ/system location of thrombo-embolic phenomena 
Organ/system Number of cases Percentage 
Pulmonary 9 50% 
Renal 3 16.6% 
Mesenteric 2 11.1% 
Cardiac 1 5.6% 
Hepatic 1 5.6% 
Cerebral 2 11.1% 
Total 18 100% 
